Shannon Maclean, DO in Kirtland Afb, NM - General Practice

Shannon Maclean, DO is a General Practice physician based in Kirtland Afb, New Mexico. Shannon Maclean is licensed to practice in Colorado (license number DR.0051993) and her current practice location is 2050a 2nd St Se, Kirtland Afb, New Mexico. She can be reached at her office (for appointments etc.) via phone at (253) 968-1110.

NPI number for Shannon Maclean is 1376799817 and her current mailing address is 2050a 2nd St Se, Kirtland Afb, New Mexico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1376799817.

Contact Information

	Shannon Maclean, DO
	2050a 2nd St Se, Kirtland Afb, NM 87117-1110
	(253) 968-1110
	Not Available

Physician's Profile

Full Name	Shannon Maclean
Gender	Female
Speciality	General Practice
Location	2050a 2nd St Se, Kirtland Afb, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1376799817
Provider Enumeration Date: 08/15/2008
Last Update Date: 03/29/2021

Medical Identifiers

Medical identifiers for Shannon Maclean such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376799817	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	DR.0051993 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shannon Maclean is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shannon Maclean, DO 2050a 2nd St Se, Kirtland Afb, NM 87117-5522 Ph: (505) 853-7992	Shannon Maclean, DO 2050a 2nd St Se, Kirtland Afb, NM 87117-1110 Ph: (253) 968-1110

News Archive

Eisai seeks simultaneous approval of eribulin mesylate in U.S., EU and Japan

Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.

John O'Keefe, May-Britt Moser and Edvard I. Moser win 2014 Nobel Prize in Physiology or Medicine

The 2014 Nobel Prize in Physiology or Medicine has been awarded with one half to John O'Keefe and the other half jointly to May-Britt Moser and Edvard I. Moser "for their discoveries of cells that constitute a positioning system in the brain".

Congressional appropriations decisions will affect women's health worldwide

"[E]vidence shows that family planning prevents the needless deaths of women worldwide," which should "be cause to sustain or even increase U.S. investments in these programs," Chloe Cooney, director of global advocacy for the Planned Parenthood Federation of America (PPFA), writes in this RH Reality Check blog post.

RAD Technology Medical Systems announces breast cancer awareness campaign to support Breastcancer.org

RAD Technology Medical Systems LLC in conjunction with BREASTCANCER.ORG announced a unique awareness campaign that will start this week with the transit of the first Temporary Radiotherapy Vault. RAD has pioneered patented designs for radiotherapy vaults and clinics.

Shannon Maclean, DO - General Practice in Kirtland Afb, NM